RxDoctor Payments Data

Carin Litani, MD

MOHS-Micrographic Surgery · Wellesley Hills, MANPI 1326209560

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.

$4,554in general payments, 2019–2025

Across 165 payments — averaging $27.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$807
  • Revance Therapeutics, Inc.$590
  • Lilly USA, LLC$581
  • Merz North America, Inc.$353
  • Regeneron Healthcare Solutions, Inc.$327
  • Novartis$229
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,554100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,554 in reported general payments places this provider in the 80th percentile of 38 mohs-micrographic surgery providers in Massachusetts.

See all mohs-micrographic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$685,624
Medicare patients
1,064
Services billed
4,761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate13$840
Doxycycline Monohydrate40$638
Cephalexin90$357
Minoxidil28$242
Mupirocin35$196
Triamcinolone Acetonide25$196
ValacyclovirValacyclovir Hcl27$182
Spironolactone43$167
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$45
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$26
Tramadol Hcl12$17

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Wellesley Hills

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →